Do the results of pregnancy registries contradict one another?
作者信息
Harden Cynthia L
出版信息
Epilepsy Curr. 2006 May-Jun;6(3):73-5. doi: 10.1111/j.1535-7511.2006.00102.x.
Abstract
摘要
相似文献
1
Do the results of pregnancy registries contradict one another?妊娠登记处的结果相互矛盾吗？
Epilepsy Curr. 2006 May-Jun;6(3):73-5. doi: 10.1111/j.1535-7511.2006.00102.x.
2
Supplemental staffing: can it be cost-effective?补充人员配置：它具有成本效益吗？
Hospitals. 1981 Mar 16;55(6):74-7.
3
Clinical trials registries are underused in the pregnancy and childbirth literature: a systematic review of the top 20 journals.临床试验注册在妊娠和分娩文献中的应用不足：对排名前20的期刊的系统评价
BMC Res Notes. 2016 Oct 21;9(1):475. doi: 10.1186/s13104-016-2280-3.
4
A systematic review of pregnancy exposure registries: examination of protocol-specified pregnancy outcomes, target sample size, and comparator selection.妊娠暴露登记系统评价：对方案规定的妊娠结局、目标样本量和对照选择的审查。
Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):208-214. doi: 10.1002/pds.4150. Epub 2016 Dec 27.
5
Antiepileptic drug exposure and major congenital malformations: the role of pregnancy registries.抗癫痫药物暴露与重大先天性畸形：妊娠登记处的作用。
Epilepsy Behav. 2007 Nov;11(3):277-82. doi: 10.1016/j.yebeh.2007.08.015.
6
Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment.通过前瞻性妊娠登记监测产前药物暴露后的妊娠结局：制药公司的承诺。
Am J Obstet Gynecol. 2000 Jan;182(1 Pt 1):159-63. doi: 10.1016/s0002-9378(00)70506-0.
7
Utilization of drugs with pregnancy exposure registries during pregnancy.孕期使用设有孕期暴露登记处的药物。
Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):604-611. doi: 10.1002/pds.4409. Epub 2018 Mar 8.
8
Pregnancy exposure registries.孕期暴露登记处。
Drug Saf. 2004;27(4):215-28. doi: 10.2165/00002018-200427040-00001.
9
Rationale and design of two prospective, multicenter, observational studies on reproductive outcome in women with recurrent failures after spontaneous or assisted conception: OTTILIA and FIRST registries.关于自然或辅助受孕后反复失败的女性生殖结局的两项前瞻性、多中心观察性研究：OTILLIA 和 FIRST 注册研究的背景和设计。
BMC Pregnancy Childbirth. 2019 Aug 13;19(1):292. doi: 10.1186/s12884-019-2444-y.
10
Monitoring pregnancy outcomes following prenatal drug exposure through prospective pregnancy registries and passive surveillance: a pharmaceutical company commitment.通过前瞻性妊娠登记和被动监测来监测产前药物暴露后的妊娠结局：制药公司的承诺。
Prim Care Update Ob Gyns. 1998 Jul 1;5(4):190-191. doi: 10.1016/s1068-607x(98)00115-2.
本文引用的文献
1
Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.孕期抗癫痫药物的致畸风险：来自英国癫痫与妊娠登记处的一项前瞻性研究。
J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):193-8. doi: 10.1136/jnnp.2005.074203. Epub 2005 Sep 12.
2
Maternal valproate dosage and foetal malformations.母亲丙戊酸盐剂量与胎儿畸形
Acta Neurol Scand. 2005 Sep;112(3):137-43. doi: 10.1111/j.1600-0404.2005.00458.x.
3
Increased rate of major malformations in offspring exposed to valproate during pregnancy.孕期接触丙戊酸盐的后代中严重畸形发生率增加。
Neurology. 2005 Mar 22;64(6):961-5. doi: 10.1212/01.WNL.0000154516.43630.C5.
4
The AED (antiepileptic drug) pregnancy registry: a 6-year experience.抗癫痫药物（AED）妊娠登记处：六年经验
Arch Neurol. 2004 May;61(5):673-8. doi: 10.1001/archneur.61.5.673.
5
The impact of pregnancy and childbirth on the metabolism of lamotrigine.妊娠和分娩对拉莫三嗪代谢的影响。
Neurology. 2004 Jan 27;62(2):292-5. doi: 10.1212/01.wnl.0000103286.47129.f8.
6
Random error and undercounting in birth defects surveillance data: implications for inference.出生缺陷监测数据中的随机误差和漏报：对推断的影响。
Birth Defects Res A Clin Mol Teratol. 2003 Sep;67(9):610-6. doi: 10.1002/bdra.10110.
7
Lamotrigine clearance during pregnancy.
Neurology. 2002 Jul 23;59(2):251-5. doi: 10.1212/wnl.59.2.251.
8
[Neural tube malformations in children of mothers treated with sodium valproate].
Rev Neurol (Paris). 1985;141(1):61-2.
Zotero 插件